Logo image of MTEX

MANNATECH INC (MTEX) Stock Fundamental Analysis

USA - NASDAQ:MTEX - US5637712036 - Common Stock

9.363 USD
+0.31 (+3.46%)
Last: 10/23/2025, 4:30:02 PM
Fundamental Rating

2

MTEX gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 33 industry peers in the Personal Care Products industry. MTEX has a bad profitability rating. Also its financial health evaluation is rather negative. MTEX is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

MTEX had negative earnings in the past year.
MTEX had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: MTEX reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: MTEX reported negative operating cash flow in multiple years.
MTEX Yearly Net Income VS EBIT VS OCF VS FCFMTEX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M

1.2 Ratios

With a Return On Assets value of -11.92%, MTEX is not doing good in the industry: 81.82% of the companies in the same industry are doing better.
With a Return On Equity value of -65.53%, MTEX is not doing good in the industry: 78.79% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -11.92%
ROE -65.53%
ROIC N/A
ROA(3y)-2.56%
ROA(5y)3.68%
ROE(3y)-8.05%
ROE(5y)8.05%
ROIC(3y)N/A
ROIC(5y)N/A
MTEX Yearly ROA, ROE, ROICMTEX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

In the last couple of years the Profit Margin of MTEX has remained more or less at the same level.
In the last couple of years the Operating Margin of MTEX has declined.
Looking at the Gross Margin, with a value of 75.79%, MTEX belongs to the top of the industry, outperforming 84.85% of the companies in the same industry.
MTEX's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for MTEX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 75.79%
OM growth 3Y-40.07%
OM growth 5Y-21.47%
PM growth 3Y-29.9%
PM growth 5Y0.19%
GM growth 3Y-0.43%
GM growth 5Y-0.61%
MTEX Yearly Profit, Operating, Gross MarginsMTEX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

2

2. Health

2.1 Basic Checks

MTEX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MTEX has been increased compared to 1 year ago.
MTEX has less shares outstanding than it did 5 years ago.
The debt/assets ratio for MTEX is higher compared to a year ago.
MTEX Yearly Shares OutstandingMTEX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M
MTEX Yearly Total Debt VS Total AssetsMTEX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

An Altman-Z score of 3.66 indicates that MTEX is not in any danger for bankruptcy at the moment.
MTEX has a Altman-Z score (3.66) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.58 indicates that MTEX is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.58, MTEX is not doing good in the industry: 63.64% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF N/A
Altman-Z 3.66
ROIC/WACCN/A
WACC9.02%
MTEX Yearly LT Debt VS Equity VS FCFMTEX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

MTEX has a Current Ratio of 1.11. This is a normal value and indicates that MTEX is financially healthy and should not expect problems in meeting its short term obligations.
MTEX has a Current ratio of 1.11. This is in the lower half of the industry: MTEX underperforms 75.76% of its industry peers.
A Quick Ratio of 0.49 indicates that MTEX may have some problems paying its short term obligations.
MTEX's Quick ratio of 0.49 is on the low side compared to the rest of the industry. MTEX is outperformed by 87.88% of its industry peers.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 0.49
MTEX Yearly Current Assets VS Current LiabilitesMTEX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

0

3. Growth

3.1 Past

The earnings per share for MTEX have decreased strongly by -220.46% in the last year.
Measured over the past years, MTEX shows a decrease in Earnings Per Share. The EPS has been decreasing by -0.73% on average per year.
MTEX shows a decrease in Revenue. In the last year, the revenue decreased by -7.72%.
MTEX shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.66% yearly.
EPS 1Y (TTM)-220.46%
EPS 3Y-34.31%
EPS 5Y-0.73%
EPS Q2Q%-585.29%
Revenue 1Y (TTM)-7.72%
Revenue growth 3Y-9.65%
Revenue growth 5Y-5.66%
Sales Q2Q%-7.43%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MTEX Yearly Revenue VS EstimatesMTEX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

0

4. Valuation

4.1 Price/Earnings Ratio

MTEX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MTEX Price Earnings VS Forward Price EarningsMTEX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as MTEX.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 19.81
MTEX Per share dataMTEX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 8.83%, MTEX is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 5.87, MTEX pays a better dividend. On top of this MTEX pays more dividend than 93.94% of the companies listed in the same industry.
MTEX's Dividend Yield is rather good when compared to the S&P500 average which is at 2.35.
Industry RankSector Rank
Dividend Yield 8.83%

5.2 History

MTEX has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
MTEX Yearly Dividends per shareMTEX Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 0.5 1 1.5 2

5.3 Sustainability

DP0%
EPS Next 2YN/A
EPS Next 3YN/A
MTEX Yearly Income VS Free CF VS DividendMTEX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M

MANNATECH INC

NASDAQ:MTEX (10/23/2025, 4:30:02 PM)

9.363

+0.31 (+3.46%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)08-12 2025-08-12
Earnings (Next)11-11 2025-11-11
Inst Owners18.95%
Inst Owner Change0.12%
Ins Owners44.9%
Ins Owner Change0%
Market Cap17.79M
Revenue(TTM)112.97M
Net Income(TTM)-3908000
Analysts0
Price TargetN/A
Short Float %0.85%
Short Ratio0.41
Dividend
Industry RankSector Rank
Dividend Yield 8.83%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.16
P/FCF N/A
P/OCF N/A
P/B 2.98
P/tB 2.98
EV/EBITDA 19.81
EPS(TTM)-2.05
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.48
FCFYN/A
OCF(TTM)-1.07
OCFYN/A
SpS59.46
BVpS3.14
TBVpS3.14
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -11.92%
ROE -65.53%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 75.79%
FCFM N/A
ROA(3y)-2.56%
ROA(5y)3.68%
ROE(3y)-8.05%
ROE(5y)8.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-40.07%
OM growth 5Y-21.47%
PM growth 3Y-29.9%
PM growth 5Y0.19%
GM growth 3Y-0.43%
GM growth 5Y-0.61%
F-Score3
Asset Turnover3.45
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF N/A
Debt/EBITDA 4.42
Cap/Depr 60.29%
Cap/Sales 0.69%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.11
Quick Ratio 0.49
Altman-Z 3.66
F-Score3
WACC9.02%
ROIC/WACCN/A
Cap/Depr(3y)43.45%
Cap/Depr(5y)43.17%
Cap/Sales(3y)0.53%
Cap/Sales(5y)0.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-220.46%
EPS 3Y-34.31%
EPS 5Y-0.73%
EPS Q2Q%-585.29%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-7.72%
Revenue growth 3Y-9.65%
Revenue growth 5Y-5.66%
Sales Q2Q%-7.43%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y48.43%
EBIT growth 3Y-45.85%
EBIT growth 5Y-25.91%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y55.13%
FCF growth 3Y-42.1%
FCF growth 5Y-11.9%
OCF growth 1Y62.42%
OCF growth 3Y-40.57%
OCF growth 5Y-14.4%